Literature DB >> 7637554

Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid-additional mechanisms in homocysteine induced endothelial damage?

G Frauscher1, E Karnaukhova, A Muehl, H Hoeger, B Lubec.   

Abstract

Increased plasma homocyst(e)ine is strongly correlated with occlusive arterial diseases. A series of different hypotheses have been reported including involvement of free oxygen radicals and therefore oxidative stress. We determined plasma homocyst(e)ine and homocysteic acid levels after oral low dose homocysteine thiolactone administration to rats for a period of six weeks. Plasma levels of homocyst(e)ine and triglycerides were significantly elevated in the group fed homocysteine thiolactone. GC/MS determination of ketone body formation showed that the underlying mechanism for the increase of triglycerides seems to be inhibition of fatty acid oxidation. Homocysteic acid was detected in the experimental group exclusively. The present study showing a homocyst(e)ine correlated increase of plasma triglycerides by the inhibition of fatty acid oxidation may well propose an additional role of triglycerides for vascular pathology. The presence of homocysteic acid in the experimental group only would support the free oxygen radical hypothesis for the development of vascular changes but homocysteic acid as a potent neurotransmitter could play an independent role in the pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637554     DOI: 10.1016/0024-3205(95)02009-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Hyperhomocysteinemia in patients with Behçet's disease: is it due to inflammation or therapy?

Authors:  Zeki Yesilova; Salih Pay; Cagatay Oktenli; Ugur Musabak; Kenan Saglam; S Yavuz Sanisoglu; Kemal Dagalp; M Kemal Erbil; Ismail H Kocar
Journal:  Rheumatol Int       Date:  2004-04-01       Impact factor: 2.631

Review 2.  Atherosclerosis risk factors: the possible role of homocysteine.

Authors:  P C Choy; D Mymin; Q Zhu; K Dakshinamurti; K O
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

3.  Plasma homocysteine and cysteine and risk of breast cancer in women.

Authors:  Jennifer Lin; I-Min Lee; Yiqing Song; Nancy R Cook; Jacob Selhub; JoAnn E Manson; Julie E Buring; Shumin M Zhang
Journal:  Cancer Res       Date:  2010-03-02       Impact factor: 12.701

4.  The effect of vitamin B6 and folate supplements on plasma homocysteine and serum lipids levels in patients on regular hemodialysis.

Authors:  S Ziakka; G Rammos; S Kountouris; C Doulgerakis; P Karakasis; C Kourvelou; N Papagalanis
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  Serum homocysteine in Indian adolescents.

Authors:  Pratima Anand; Shally Awasthi; Abbas Mahdi; Manoj Tiwari; G G Agarwal
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

6.  Relationship between plasma homocysteine level and lipid profiles in a community-based Chinese population.

Authors:  Mohetaboer Momin; Jia Jia; Fangfang Fan; Jianping Li; Jingtao Dou; Dafang Chen; Yong Huo; Yan Zhang
Journal:  Lipids Health Dis       Date:  2017-03-14       Impact factor: 3.876

7.  Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.

Authors:  Birger Scholz; Marcus Svensson; Henrik Alm; Karl Sköld; Maria Fälth; Kim Kultima; Céline Guigoni; Evelyne Doudnikoff; Qin Li; Alan R Crossman; Erwan Bezard; Per E Andrén
Journal:  PLoS One       Date:  2008-02-13       Impact factor: 3.240

Review 8.  Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence?

Authors:  Jan Lewerenz; Pamela Maher
Journal:  Front Neurosci       Date:  2015-12-16       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.